MARKET

ZOM

ZOM

Zomedica Corp
AMEX

Real-time Quotes | Nasdaq Last Sale

0.2222
-0.0138
-5.85%
After Hours: 0.2280 +0.0058 +2.61% 17:07 05/19 EDT
OPEN
0.2474
PREV CLOSE
0.2360
HIGH
0.2499
LOW
0.2200
VOLUME
52.37M
TURNOVER
0
52 WEEK HIGH
1.060
52 WEEK LOW
0.1750
MARKET CAP
217.73M
P/E (TTM)
-11.8824
1D
5D
1M
3M
1Y
5Y
Zomedica makes strategic investment to acquire pet monitoring platform
The veterinary health company Zomedica (NYSE:ZOM) announced Thursday the purchase of a $1.0 million convertible note of Ohio-based animal care company Structured Monitoring Products, Inc. giving it an option to
Seekingalpha · 11h ago
Zomedica Enters Into Strategic Investment And Potential Collaboration For VetGuardian Monitoring Product Line
Zomedica Corp. (NYSE:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion animals, today announced that it has purchased a $1.0
Benzinga · 12h ago
Zomedica Enters Into Strategic Investment and Potential Collaboration for VetGuardian Monitoring Product Line
ANN ARBOR, MI / ACCESSWIRE / May 19, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion animals, today announced that it has purchased a $1.
ACCESSWIRE · 12h ago
Zomedica Makes Strategic Investment, Gets Option to Rep VetGuardian Monitoring Platform
MT Newswires · 16h ago
Traders News Source Interviews Larry Heaton, CEO of Zomedica Corp.
NEW YORK, NY / ACCESSWIRE / May 18, 2022 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid cap publicly traded companies recently issued a new C-Level interview featuring Larry Heaton, CEO of Zo...
ACCESSWIRE · 1d ago
Why Zomedica Shares Are Falling Today
Zomedica Corp (NASDAQ: ZOM) shares are trading lower by 4.99% at $0.20. The company reported first-quarter earnings results during Tuesday’s after-hours session. Zomedica reported a first-quarter EPS loss of four tenths of one cent on revenue of $3.751 mil...
Benzinga · 05/11 19:51
Zomedica reports Q1 results
Zomedica press release (NYSE:ZOM): Q1 net loss of $3.9M. Revenue of $3.8M. Total revenues of $3.8 million were up 38% over the combined revenues of Zomedica and PulseVet as a
Seekingalpha · 05/10 20:50
Zomedica Announces First Quarter 2022 Revenues of $3.8 Million; 74% Gross Margin & $192.3 Million in Cash; Revenue up 38% from 2021 Combined Revenues
ANN ARBOR, MI / ACCESSWIRE / May 10, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for companion animals, reported consolidated financial results...
ACCESSWIRE · 05/10 20:25
More
No Data
Learn about the latest financial forecast of ZOM. Analyze the recent business situations of Zomedica Corp through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

0.00%Strong Buy
100.00%Buy
0.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average ZOM stock price target is 1.200 with a high estimate of 1.200 and a low estimate of 1.200.
High1.200
Average1.200
Low1.200
Current 0.2222
EPS
Actual
Estimate
-0.01-0.01-0.00-0.00
    00
Q1 2021
    0
Q2 2021
Q3 2021
    0
Q4 2021
    0
Q1 2022
Institutional Holdings
Institutions: 30
Institutional Holdings: 14.30M
% Owned: 1.46%
Shares Outstanding: 979.90M
TypeInstitutionsShares
Increased
10
618.54K
New
6
747.38K
Decreased
7
136.68K
Sold Out
15
2.83M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
+2.00%
Pharmaceuticals & Medical Research
+0.51%
Key Executives
Non-Executive Chairman/Independent Director
Jeffrey Rowe
Chief Executive Officer
Larry Heaton
Chief Financial Officer/Secretary
Ann Cotter
Chief Operating Officer
Stephanie Morley
Director
Robert Cohen
Director
Sean Whelan
Independent Director
Christopher MacLeod
Independent Director
Johnny Powers
Independent Director
Rodney Williams
No Data
No Data
About ZOM
Zomedica Corp. is a veterinary health company creating products for companion animals by focusing on the unmet needs of clinical veterinarians. The Company is developing point-of-care diagnostic platform, which is based on miniaturized laser-based Raman spectroscopy technology and is designed to detect pathogens in companion animals. It offers TRUFORMA is a diagnostic biosensor platform and the first five assays for the detection of thyroid disorders in dogs and cats and adrenal disorders in dogs. The TRUFORMA platform uses bulk acoustic wave (BAW) technology to provide a non-optical and fluorescence free detection system for use at the point-of-care. The TRUFORMA also offers complete control over the testing process from start to finish, with sensitive and specific immunoassays that allow veterinarians to make clinical decisions.

Webull offers kinds of Zomedica Corp stock information, including AMEX:ZOM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ZOM stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ZOM stock methods without spending real money on the virtual paper trading platform.